Philip D. Greenberg, MD, FAACR
Head and Member, Program in Immunology
Fred Hutchinson Cancer Research Center and University of Washington
Dr. Greenberg is a professor of Medicine and Immunology at the University of Washington, and head of the Program in Immunology at the Fred Hutchinson Cancer Research Center. His research has focused on elucidating fundamental principles of T cell and tumor interactions, developing cellular and molecular approaches to manipulate T cell immunity, and translating insights from the laboratory to treatment of cancer patients with an emphasis on adoptive therapy with genetically engineered T cells. He has received multiple professional awards, is on the scientific advisory boards of several comprehensive cancer centers and biotech companies, and is a scientific founder of Juno Therapeutics. He currently is a member of several AACR advisory committees and is an Editor-in-Chief of Cancer Immunology Research.